Purpose
to enable broad access of the potent adjuvant QS-21 to enhance the effectiveness of vaccines targeting infectious and endemic diseases in poor and developing nations
Grantee
Division
Global Health
Date
NOVEMBER 2018
Region served
GLOBAL
Committed amount
$927,365
Grant topic
Discovery and Translational Sciences,
Malaria
Duration (months)
38
Grantee location
Lexington, Massachusetts, United States
Related work
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.